Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin W Van Tassell

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
The Annals of Pharmacotherapy|March 8, 2007
Aliskiren for renin inhibition: a new class of antihypertensivesBenjamin W Van Tassell, Mark A Munger
Medgenmed : Medscape General Medicine|December 20, 2007
Medication nonadherence: an unrecognized cardiovascular risk factorMark A Munger, Benjamin W Van Tassell, Joanne LaFleur
Current Heart Failure Reports|October 16, 2014
Targeting interleukin-1 in heart failure and inflammatory heart diseaseBenjamin W Van Tassell, Juan M Valle Raleigh, Antonio Abbate
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 11, 2012
Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular eventsAntonio Abbate, Benjamin W Van Tassell, Giuseppe G L Biondi-Zoccai
Pharmacotherapy|April 28, 2007
Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatmentMark A Munger, Tien M H Ng, Benjamin W Van Tassell
Journal of the American College of Cardiology|February 18, 2014
Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarctionIgnacio M Seropian, Stefano Toldo, Benjamin W Van Tassell, et al.
Pharmacotherapy|November 26, 2008
Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failureBenjamin W Van Tassell, Przemyslaw Radwanski, Matthew Movsesian, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 22, 2017
Interleukin-1 blockade for the treatment of pericarditisLeo F Buckley, Michele M Viscusi, Benjamin W Van Tassell, et al.
American Journal of Pharmaceutical Education|September 6, 2023
Analysis of Gender and Race in Pharmacy Faculty and AdministratorsRucha Bond, Caitlin M Gibson, Azita H Talasaz, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 8, 2013
Interleukin-1β induces a reversible cardiomyopathy in the mouseBenjamin W Van Tassell, Ignacio M Seropian, Stefano Toldo, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
The Annals of Pharmacotherapy|March 8, 2007
Aliskiren for renin inhibition: a new class of antihypertensivesBenjamin W Van Tassell, Mark A Munger
Medgenmed : Medscape General Medicine|December 20, 2007
Medication nonadherence: an unrecognized cardiovascular risk factorMark A Munger, Benjamin W Van Tassell, Joanne LaFleur
Current Heart Failure Reports|October 16, 2014
Targeting interleukin-1 in heart failure and inflammatory heart diseaseBenjamin W Van Tassell, Juan M Valle Raleigh, Antonio Abbate
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 11, 2012
Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular eventsAntonio Abbate, Benjamin W Van Tassell, Giuseppe G L Biondi-Zoccai
Pharmacotherapy|April 28, 2007
Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatmentMark A Munger, Tien M H Ng, Benjamin W Van Tassell
Journal of the American College of Cardiology|February 18, 2014
Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarctionIgnacio M Seropian, Stefano Toldo, Benjamin W Van Tassell, et al.
Pharmacotherapy|November 26, 2008
Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failureBenjamin W Van Tassell, Przemyslaw Radwanski, Matthew Movsesian, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 22, 2017
Interleukin-1 blockade for the treatment of pericarditisLeo F Buckley, Michele M Viscusi, Benjamin W Van Tassell, et al.
American Journal of Pharmaceutical Education|September 6, 2023
Analysis of Gender and Race in Pharmacy Faculty and AdministratorsRucha Bond, Caitlin M Gibson, Azita H Talasaz, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 8, 2013
Interleukin-1β induces a reversible cardiomyopathy in the mouseBenjamin W Van Tassell, Ignacio M Seropian, Stefano Toldo, et al.
Pageof 12